SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $234,000 | -60.2% | 8,144 | 0.0% | 0.01% | -50.0% |
| Q4 2019 | $588,000 | -48.6% | 8,144 | 0.0% | 0.01% | -54.5% |
| Q3 2019 | $1,143,000 | -23.3% | 8,144 | 0.0% | 0.02% | -29.0% |
| Q2 2019 | $1,491,000 | +31.2% | 8,144 | +14.0% | 0.03% | +19.2% |
| Q1 2019 | $1,136,000 | +47.3% | 7,144 | -11.2% | 0.03% | +30.0% |
| Q4 2018 | $771,000 | -61.8% | 8,044 | -43.7% | 0.02% | -33.3% |
| Q3 2018 | $2,018,000 | +88.4% | 14,288 | +108.8% | 0.03% | +30.4% |
| Q2 2018 | $1,071,000 | +10.0% | 6,844 | +13.2% | 0.02% | +4.5% |
| Q1 2018 | $974,000 | +62.3% | 6,044 | +65.9% | 0.02% | +175.0% |
| Q4 2017 | $600,000 | – | 3,644 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |